Live Breaking News & Updates on Andrew Spaventa

Stay updated with breaking news from Andrew spaventa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Singular Genomics is latest early stage San Diego startup to seek an IPO


Print
Singular Genomics, a San Diego startup that’s developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company.
Founded in 2016, Singular hasn’t disclosed yet how much money it hopes to raise or the proposed price range of its shares. That information should be revealed as Singular gets closer to pricing its initial public stock offering.
But it is attempting an IPO at a time when investors are receptive to betting on early stage companies. There have been 141 IPOs priced globally so far this year, up more than 300 percent from the same period last year, according to Renaissance Capital, an IPO investment advisory firm. San Diego-based TuSimple, which is developing self-driving semi-truck technology, recently raised $1 billion in an IPO. ....

San Diego , United States , Eli Glezer , Andrew Spaventa , Pacific Biosciences , Nasdaq Exchange , Goldman Sachs , Thermo Fisher , Domain Associates , Singular Genomics , Renaissance Capital , Diego Based Tusimple , Deerfield Management , Legend Capital , March Venture , Bofa Securities , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பெஸிஃபிக் உயிர் அறிவியல் , நாஸ்டாக் பரிமாற்றம் , கோல்ட்மேன் சாக்ஸ் , தெர்மோ மீனவர் , களம் கூட்டாளிகள் , ஒருமை மரபியல் , மறுமலர்ச்சி மூலதனம் , தீர்ப்பியல்ட் மேலாண்மை ,